Abstract
Autoimmune retinopathies (AIRs) are a group of autoantibody-mediated retinal degenerations characterized by progressive visual deterioration, visual field loss, abnormal electroretinography (ERG) with a normal looking retina or a minimally apparent structural changes in the retina. It is characterized by the presence of antiretinal antibodies (ARAs) causing photoreceptor dysfunction. AIR is an immunologic disorder whereby retinal antigens are recognized aberrantly as autoantigens, leading to retinal degeneration as evidenced by basic immunological studies. However, exact underlying pathomechanism remains elusive. Most of the evidences are from experimental animal models. The incidence as well as the severity of the disease decreases under a germ-free environment which further strengthens the hypothesis of microbiota being a trigger for the autoimmune diseases. Four mechanisms triggering the gut-eye axis for causing intraocular inflammation have been hypothesized including antigenic (molecular) mimicry, destruction of intestinal barrier, increased intestinal permeability, microbial metabolites, dysbiosis. No standardized protocol has yet been established for patients with AIR. Considering a pivotal role of gut microbiota in autoimmune uveitis, four main therapeutic approaches are developed. This includes antibiotics, probiotics, dietary modifications, and fecal microbiota transplantation (FMT). Methionine aminopeptidase 2 (MetAP2) inhibitors like lodamine have shown to have significantly reduced the inflammatory cell infiltration and granuloma formation. The intestinal microbiome thus represents a salient potential target for therapeutic modulation to treat these potentially blinding conditions. Prospective studies are required to analyze the proposed experimental therapeutic approaches for a clinical implication.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamus G (2003) Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev 2(2):6368
Adamus G (2009) Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev 8(5):410–414
Adamus G, Ren G, Weleber RG (2004) Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4:5
Adamus G, Webb S, Shiraga S, Duvoisin RM (2006) Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun 26(2):146–153
Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL et al (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL27/STAT1. Nat Med 13:711–718
Anderson J, Fuglsang H (1976) Effects of diethylcarbamazine on ocular onchocerciasis. Trop Med Parasitol 27:263
Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ et al (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395–1401
Atarashi K, Tanoue T, Shima T et al (2011) Induction of colonic regulatory T cells by indigenous clostridium species. Science 331:337–341
Avni O, Koren O (2018) Molecular (me)micry? Cell Host Microbe 23(5):576–578
Beli E, Yan Y, Moldovan L, Vieira CP, Gao R, Duan Y et al (2018) Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice. Diabetes 67(9):1867–1879
Benny O, Fainaru O, Adini A, Cassiola F, Bazinet L et al (2008) An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nat Biotechnol 26:799–807
Benny O, Nakai K, Yoshimura T, Bazinet L, Akula JD et al (2010) Broad spectrum antiangiogenic treatment for ocular neovascular diseases. PLoS One 5:e12515
Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345–350
Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28:203–209
Caspi RR (2010) A look at autoimmunity and inflammation in the eye. J Clin Invest 120(9):3073–3083
Caspi RR, Roberge FG, McAllister CG, El-Saied M, Kuwabara T, Gery I, Hanna E, Nussenblatt RB (1986) T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 136:928
Cavuoto KM, Banerjee S, Galor A (2019) Relationship between the microbiome and ocular health. Ocul Surf 17(3):384–392
Chen H, Cho KS, Vu THK, Shen CH, Kaur M, Chen G et al (2018) Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun 9(1):3209
Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H et al (2019) Fecal microbiota transplantation for the treatment of recurrent and severe clostridium difficile infection in solid organ transplant recipients: a multicenter experience. Am J Transplant 19(2):501–511
Chi W, Zhu X, Yang P, Liu X, Lin X et al (2008) Upregulated IL-23 and IL17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 49:3058–3064
Choi RY, Asquith M, Rosenbaum JT (2018) Fecal transplants in spondyloarthritis and uveitis: ready for a clinical trial? Curr Opin Rheumatol 30(4):303–309
Ciccia F, Guggino G, Rizzo A, Alessandro R, Luchetti MM, Milling S et al (2017) Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis 76(6):1123–1132
Collison J (2018) Bacterial orthologues of Ro60 trigger disease. Nat Rev Rheumatol 14(6):322
Colpitts SL, Kasper EJ, Keever A, Liljenberg C, Kirby T, Magori K et al (2017) A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis. Gut Microbes 8:561–573. https://doi.org/10.1080/19490976.2017.1353843
Cree BA, Spencer CM, Varrin-Doyer M, Baranzini SE, Zamvil SS (2016) Gut microbiome analysis in neuromyelitis optica reveals overabundance of clostridium perfringens. Ann Neurol 80(3):443–447
Dalal MD, Morgans CW, Duvoisin RM et al (2013) Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach. Ophthalmology 120(12):2560–2564
De Kozak Y, Sainte-Laudy J, Benveniste J, Faure JP (1981) Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis. Eur J Immunol 11:612
De Paiva CS, Jones DB, Stern ME et al (2016) Altered mucosal microbiome diversity and disease severity in sj€ogren syndrome. Sci Rep 6:23561
Dot C, Guigay J, Adamus G (2005) Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. Am J Ophthalmol 139:746–747
Doulberis M, Polyzos SA, Papaefthymiou A, Katsinelos P, Kountouras J (2019) Comments to the editor concerning the paper entitled “the microbiome and ophthalmic disease” by Baim et al. Exp Biol Med 244(6):430–432
Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI (2004) Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 88(9):1159–1162
Ferreyra HA, Jayasundera T, Khan NW, He S, Lu Y, Heckenlively JR (2009) Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol 127(4):390–397
Flint HJ, Duncan SH, Louis P (2017) The impact of nutrition on intestinal bacterial communities. Curr Opin Microbiol 38:59–65
Gareau MG (2016) Cognitive function and the microbiome. Int Rev Neurobiol 131:227–246. https://doi.org/10.1016/bs.irn.2016.08.001
Gianchecchi E, Fierabracci A (2019) Recent advances on microbiota involvement in the pathogenesis of autoimmunity. Int J Mol Sci 20(2):283
Gough E, Shaikh H, Manges AR (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53:994–1002
Gray DH, Gavanescu I, Benoist C, Mathis D (2007) Danger-free autoimmune disease in Aire-deficient mice. Proc Natl Acad Sci U S A 104:18193–18198. https://doi.org/10.1073/pnas.0709160104
Greiling TM, Dehner C, Chen X, Hughes K, Iñiguez AJ, Boccitto M et al (2018) Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med 10(434):eaan2306
Griffith EC, Su Z, Niwayama S, Ramsay CA, Chang YH et al (1998) Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc Natl Acad Sci U S A 95:15183–15188
Gritz EC, Bhandari V (2015) The human neonatal gut microbiome: a brief review. Front Pediatr 3:17
Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ (2010) The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov 9:325–338
Heissigerova J, Seidler Stangova P, Klimova A, Svozilkova P, Hrncir T, Stepankova R et al (2016) The microbiota determines susceptibility to experimental autoimmune uveoretinitis. J Immunol Res 2016:5065703
Horai R, Caspi RR (2010) Retinal inflammation: uveitis/uveoretinitis. In: Pang I-H, Clark AF (eds) Animal models for retinal diseases, Neuromethods. Springer, Fort Worth, TX, pp 207–225. https://doi.org/10.1007/978-1-60761-541-5
Horai R, Caspi RR (2019) Microbiome and autoimmune uveitis. Front Immunol 10:232
Horai R, Zárate-Bladés CR, Dillenburg-Pilla P, Chen J, Kielczewski JL, Silver PB et al (2015) Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity 43(2):343–353
Huang X, Ye Z, Cao Q, Su G, Wang Q, Deng J et al (2018) Gut microbiota composition and fecal metabolic phenotype in patients with acute anterior uveitis. Invest Ophthalmol Vis Sci 59(3):1523–1531
Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498
Janowitz C, Nakamura YK, Metea C, Gligor A, Yu W, Karstens L et al (2019) Disruption of intestinal homeostasis and intestinal microbiota during experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 60(1):420–429
Kassam F, Gurry T, Aldarmaki A, Nguyen T, Kassam Z, Beck PL et al (2018) Sa1841: the impact of the gut microbiome in developing uveitis among inflammatory bowel disease patients: a case-control study. Gastroenterology 154(6):S–415
Kim J, Choi SH, Kim YJ, Jeong HJ, Ryu JS, Lee HJ et al (2017) Clinical effect of IRT-5 probiotics on immune modulation of autoimmunity or alloimmunity in the eye. Nutrients 9(11):1166
Knight R et al (2017) The microbiome and human biology. Annu Rev Genomics Hum Genet 18:6586
Kugadas A, Gadjeva M (2016) Impact of microbiome on ocular health. Ocular Surface 14(3):342–349
Kugadas A, Wright Q, Geddes-McAlister J, Gadjeva M (2017) Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA. Invest Ophthalmol Vis Sci 58:4593–4600. https://doi.org/10.1167/iovs.17-22119
Larson TA, Gottlieb CC, Zein WM et al (2010) Autoimmune retinopathy: prognosis and treatment. Invest Ophthalmol Vis Sci 51:ARVO E-Abstract 6375
Leccese P, Alpsoy E (2019) Behçet’s disease: an overview of etiopathogenesis. Front Immunol 10(MAY):1067
Lee YK, Menezes JS, Umesaki Y, Mazmanian SK (2011) Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 108(Suppl 1):4615–4622
Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41(1):262–266
Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E (2017) Dysbiosis and the immune system. Nat Rev Immunol 17(4):219–232
Lin P (2018) The role of the intestinal microbiome in ocular inflammatory disease. Curr Opin Ophthalmol 29(3):261–266
Lin P (2019) Importance of the intestinal microbiota in ocular inflammatory diseases: a review. Clin Exp Ophthalmol 47(3):418–422
Maes M, Kubera M, Mihaylova I, Geffard M, Galecki P, Leunis JC et al (2013) Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. J Affect Disord 149(1–3):23–29
Magrys A, Anekonda T, Ren G, Adamus G (2007) The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmunemediated retinopathy. J ClinImmunol 27(2):181–192
Marak GE Jr, Wacker WB, Rao NA, Jack R, Ward PA (1979) Effects of complement depletion on experimental allergic uveitis. Ophthalmic Res 11:97
Marchesi JR, Ravel J (2015) The vocabulary of microbiome research: a proposal. Microbiome. 3:31
Mauriz J, Gonzalez P, Duran M, Molpeceres V, Culebras J et al (2007) Cellcycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism. Transl Res 149:46–53
McEwen BS, Biron CA, Brunson KW, Bulloch K, Chambers WH et al (1997) The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev 23:79–133
Merryman CF, Donoso LA, Sery TW, Sciutto E, Bauer A, Shinohara T (1987) S-antigen: adoptive transfer of experimental autoimmune uveitis following immunization with a small synthetic peptide. Arch Ophthalmol 105:841
Miraglia F, Colla E (2019) Microbiome, parkinson’s disease and molecular mimicry. Cell 8(3):222
Miserocchi E, Fogliato G, Modorati G, Bandello F (2013) Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol 23:705–717. https://doi.org/10.5301/ejo.5000278
Mochizuki M, Kuwabara T, McAllister CG, Nussenblatt RB, Gery I (1985) Adoptive transfer of experimental autoimmune uveoretinitis in rats: immunopathogenic mechanisms and histologic features. Invest Ophthalmol Vis Sci 26:1
Mochizuki M, Sugita S, Kamoi K (2013) Immunological homeostasis of the eye. Prog Retin Eye Res 33:10–27
Nakamura YK, Metea C, Karstens L, Asquith M, Gruner H, Moscibrocki C et al (2016) Gut microbial alterations associated with protection from autoimmune uveitis. Invest Ophthalmol Vis Sci 57(8):3747–3758
Nakamura YK, Janowitz C, Metea C, Asquith M, Karstens L, Rosenbaum JT et al (2017) Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep 7(1):11745
Neumann E, Gunders E (1973) Pathogenesis of the posterior segment lesion of ocular onchocerciasis. Am J Ophthalmol 75:82
O’Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7(7):688–693
Ochoa-Reparaz J, Mielcarz DW, Ditrio LE et al (2010) Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide a expression. J Immunol 185:4101–4108
Ochoa-Reparaz J, Kirby TO, Kasper LH (2018) The gut microbiome and multiple sclerosis. Cold Spring Harb Perspect Med 8
Okai S, Usui F, Yokota S et al (2016) High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice. Nat Microbiol 1:16103
Okel BB, Thirkill CE, Anderson K (1995) An unusual case of melanoma-associated retinopathy. Ocul Immunol Inflamm 3:121–128
Patnaik G, Sobrin L, Biswas J (2020) Chapter 10, autoimmune retinopathy. In: Inflammation, 1st edn. ChanRe Publishers, Bengaluru, p 109
Paul EV, Zimmerman LE (1970) Some observations on the ocular pathology of onchocerciasis. Hum Pathol 1:581
Picchianti-Diamanti A, Rosado MM, D’Amelio R (2017) Infectious agents and inflammation: the role of microbiota in autoimmune arthritis. Front Microbiol 8:2696
Proekt I, Miller CN, Jeanne M, Fasano KJ, Moon JJ, Lowell CA et al (2016) LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity. J Clin Invest 126:3758–3771. https://doi.org/10.1172/JCI84440
Qiu Y, Zhu Y, Yu H et al (2018) Dynamic DNA methylation changes of Tbx21 and Rorc during experimental autoimmune uveitis in mice. Mediat Inflamm 2018:1–13
Reháková Z, Capková J, Stĕpánková R, Sinkora J, Louzecká A, Ivanyi P et al (2000) Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Hum Immunol 61(6):555–558
Rinninella E, Mele MC, Merendino N, Cintoni M, Anselmi G, Caporossi A et al (2018) The role of diet, micronutrients and the gut microbiota in age-related macular degeneration: new perspectives from the gut–retina axis. Nutrients 10(11):1677
Rinninella E, Raoul P, Cintoni M et al (2019) What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7(1):14
Riviere A, Selak M, Lantin D et al (2016) Bifidobacteria and butyrate- producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 7:979
Robles Alonso V, Guarner F (2013) Linking the gut microbiota to human health. Br J Nutr 109(Suppl 2):S21–S26
Rodger FC, Chir M (1960) The pathogenesis and pathology of ocular onchocerciasis. Am J Ophthalmol 49:327
Rojas M, Restrepo-Jiménez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C et al (2018) Molecular mimicry and autoimmunity. J Autoimmun 95:100–123
Rosenbaum JT, Asquith M (2018) The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol 14(12):704–713
Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107:12204–12209
Rowan S, Jiang S, Korem T, Szymanski J, Chang ML, Szelog J et al (2017) Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci U S A 114(22):E4472–E4481
Sampson TR, Mazmanian SK (2015) Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17:565–576. https://doi.org/10.1016/j.chom.2015.04.011
Shimizu J, Kubota T, Takada E, Takai K, Fujiwara N, Arimitsu N et al (2016) Bifidobacteria abundance-featured gut microbiota compositional change in patients with Behcet’s disease. PLoS One 11(4):e0153746
Slavin J (2013) Fiber and prebiotics: mechanisms and health benefits. Nutrients 5(4):1417–1435
Smith PM, Howitt MR, Panikov N et al (2013) The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569–573
Szablewski L (2018) Human gut microbiota in health and Alzheimer’s disease. J Alzheimers Dis 62(2):549–560
Tan TG, Sefik E, Geva-Zatorsky N et al (2016) Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci U S A 113:E8141–E8150
Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474(11):1823–1836
Tomura M, Yoshida N, Tanaka J, Karasawa S, Miwa Y, Miyawaki A et al (2008) Monitoring cellular movement in vivo with photoconvertible fluorescence protein “Kaede” transgenic mice. Proc Natl Acad Sci USA 105:10871–10876. https://doi.org/10.1073/pnas.0802278105
Trujillo-Vargas CM, Schaefer L, Alam J, Pflugfelder SC, Britton RA, de Paiva CS (2019) The gut-eyelacrimal gland-microbiome axis in Sjogren syndrome. Ocul Surf 18(2):335–344
Tsunoda I (2017) Lymphatic system and gut microbiota affect immunopathology of neuroinflammatory diseases, including multiple sclerosis, neuromyelitis optica and Alzheimer’s disease. Clin Exp Neuroimmunol 8(3):177–179
Ueda Y, Kawakami Y, Kunii D, Okada H, Azuma M, Le DS et al (2008) Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease. Nutr Res 28(4):239–244
Van der Lelij A, Rothova A, Stilma JS, Hoekzema R, Kijlstra A (1990) Cell-mediated immunity against human retinal extract, S-antigen, and Interphotoreceptor retinoid binding protein in Onchocercal Chorioretinopathy. Invest Ophthalmol Vis Sci 31(10):2031–2036
Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, Nelson PA, Stroud RM, Cree BA et al (2012) Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize clostridium ABC transporter. Ann Neurol 72(1):53–64
Verhagen FH et al (2018) A disease-associated microRNA cluster links inflammatory pathways and an altered composition of leukocyte subsets to noninfectious uveitis. Investig Ophthalmol Vis Sci 59(2):878–888
Vieira SM, Pagovich OE, Kriegel MA (2014) Diet, microbiota and autoimmune diseases. Lupus 23(6):518–526
Vrancken G, Gregory AC, Huys GRB et al (2019) Synthetic ecology of the human gut microbiota. Nat Rev Microbiol 17(12):754–763
Watters GA, Turnbull PR, Swift S et al (2017) Ocular surface microbiome in meibomian gland dysfunction. Clin Exp Ophthalmol 45(2):105–111
Wekerle H (2016) The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria. Rheumatology 55:ii68–ii75. https://doi.org/10.1093/rheumatology/kew353
Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC et al (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455(7216):1109–1113
Wen C, Zheng Z, Shao T, Liu L, Xie Z, Le Chatelier E et al (2017) Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome Biol 18(1):142
Wen X, Hu X, Miao L et al (2018) Epigenetics, microbiota, and intraocular inflammation: new paradigms of immune regulation in the eye. Prog Retin Eye Res 64:84–95
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP (2015) The microbiome of the urinary tract: a role beyond infection. Nat Rev Urol 12(2):81–90
Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y et al (2010) Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32(6):815–827
Xiangyu F, Chen Y, Chen D (2021) The role of gut microbiome in autoimmune uveitis. Ophthalmic Res 64:168–177. https://doi.org/10.1159/000510212
Xiong WH, Duvoisin RM, Adamus G, Jeffrey BG, Gellman C, Morgans CW (2013) Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice. PLoS One 8(8):e69506
Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X et al (2018) A metagenomic study of the gut microbiome in Behcet’s disease. Microbiome 6(1):135
Ye Z, Wu C, Zhang N, Du L, Cao Q, Huang X et al (2020) Altered gut microbiome composition in patients with Vogt-Koyanagi-Harada disease. Gut Microbes 11(3):539–517
Zaheer M et al (2018) Protective role of commensal bacteria in Sjögren syndrome. J Autoimmun 93:45–56
Zarate-Blades CR, Horai R, Mattapallil MJ, Ajami NJ, Wong M, Petrosino JF et al (2017) Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site. Gut Microbes 8:59–66. https://doi.org/10.1080/19490976.2016.1273996
Zeng Q, Junli Gong G, Liu X, Chen C, Sun X, Li H et al (2019) Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis. Neurochem Int 129:104468
Zhang Y, Griffith E, Sage J, Jacks T, Liu J (2000) Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc Natl Acad Sci U S A 97:6427–6432
Zhuang Z, Wang Y, Zhu G, Gu Y, Mao L, Hong M et al (2017) Imbalance of Th17/Treg cells in pathogenesis of patients with human leukocyte antigen B27 associated acute anterior uveitis. Sci Rep 7:40414
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Patnaik, G., Biswas, J. (2022). Role of Microorganisms in Pathogenesis and Management of Autoimmune Retinopathy (AIR). In: Dwivedi, M.K., Sankaranarayanan, A., Kemp, E.H., Shoenfeld, Y. (eds) Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-19-4800-8_21
Download citation
DOI: https://doi.org/10.1007/978-981-19-4800-8_21
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-4799-5
Online ISBN: 978-981-19-4800-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)